Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

contentuptodate· Content· item f22_8_22669

©2013 UpToDate ® Print Email Bezafibrate improves outcome in subgroup of patients with elevated triglycerides In the Bezafibrate Prevention trial of 3090 patients, bezafibrate therapy reduced the primary endpoint (fatal and nonfatal MI and sudden death) by 40 percent in the subgroup of patients with baseline triglycerides ≥200 mg/dL (13 versus 22.3 percent for placebo, p = 0.02). Data from The Bezafibrate Prevention (BIP) study investigators, Circulation 2000; 102:21.